Assisted Reproductive Technology Market by Trend, Share,
Size and Streamline Inspection and Forecast to 2030
Assisted
Reproductive Technology Market size was estimated at USD 27,489.0
million in 2024 and is projected to reach USD 40,790.46 million in 2031 at a
CAGR of 5.8 % during the forecast period 2025-2031.
The assisted reproductive technology (ART) market refers to
the range of medical technologies and procedures that assist individuals or
couples in achieving pregnancy. These technologies include in vitro
fertilization (IVF), intrauterine insemination (IUI), egg/sperm donation, and
surrogacy, among others.
Get Free Sample
Report: https://www.delvens.com/get-free-sample/assisted-reproductive-technology-market
Impacts USA tariff
rates on the Assisted Reproductive Technology Market
The 2025 U.S.
tariffs introduced by President Donald Trump have notably impacted the Assisted
Reproductive Technology (ART) market by increasing the cost of essential
medical devices and pharmaceuticals. Tariffs on imports from key manufacturing
countries have led to higher prices for critical components used in ART
procedures, such as incubators, cryopreservation media, and fertility
medications.
This escalation in costs has compelled ART providers to
either absorb the additional expenses, thereby reducing profit margins, or pass
them on to patients, potentially limiting access to fertility treatments.
Furthermore, the tariffs have disrupted global supply chains, causing delays in
the availability of necessary equipment and medications, which can adversely
affect the scheduling and success rates of ART procedures. These challenges
have introduced a degree of uncertainty and volatility in the ART market,
potentially slowing its growth in the near term.
Delvens Industry
Expert's Standpoint on Assisted Reproductive Technology Market
Experts in the Assisted Reproductive Technology Market
highlight several key trends driving growth and innovation. The assisted
reproductive technology (ART) market involves medical technologies like IVF,
IUI, egg/sperm donation, and surrogacy to assist individuals and couples in
overcoming infertility challenges.
With a focus on personalized care, the market includes
fertility clinics, hospitals, and specialized centers, driven by advancements
in genetics, cryopreservation, and AI. Rising infertility rates, delayed
childbearing, and increasing awareness are key market drivers, while trends
such as egg freezing, fertility preservation, and fertility tourism are contributing
to its growth. Technological innovations and broader societal acceptance are
shaping the ART market, making reproductive healthcare more accessible and
diverse.
The Prominent Players
in the Assisted Reproductive Technology Market are
·
Cosmos Biomedical Ltd.
·
Microm U.K. Ltd.
·
CooperSurgical, Inc.
·
FUJIFILM Irvine Scientific
·
Cryolab Ltd.
·
Vitrolife AB
·
European Sperm Bank
·
Bloom IVF Centre
·
Merck KGaA
·
Ferring B.V. and More
For More Inquiry
Contact us: https://www.delvens.com/Inquire-before-buying/assisted-reproductive-technology-market
Analyst view on the
impacts of U.S. tariff rates on the Assisted Reproductive Technology Market
·
Despite these challenges, the ART market is
anticipated to maintain long-term growth, driven by factors such as increasing
infertility rates, advancements in reproductive technologies, and a growing
societal acceptance of ART procedures. The demand for ART services remains
robust, as individuals and couples continue to seek solutions for infertility.
·
Moreover, the market is expected to adapt by
exploring alternative supply chains and investing in domestic manufacturing to
mitigate the impact of tariffs. Innovations in ART, including the development
of more efficient and cost-effective procedures, are also likely to contribute
to market resilience. As the industry navigates these challenges, it is poised
to emerge stronger, with a more diversified and robust infrastructure to
support sustained growth.
Recent Developments
·
In
January 2024, Ivy Fertility teamed up with fertility specialty pharmacy SMP
Pharmacy Solutions to improve the patient experience across Ivy’s 13 fertility
centers through a joint co-branding initiative. This strategic partnership
aimed to enhance service delivery and offer patients comprehensive support,
while also benefiting both companies with stronger offerings and increased
patient satisfaction.
·
In
October 2023, Hamilton Thorne Ltd. acquired Gynetics Medical Products, N.V.
and Gynetics Services B.V., a leading manufacturer of innovative, high-quality
In-vitro fertilization (IVF) devices. This acquisition broadened Hamilton
Thorne's product portfolio, boosting its position and competitive edge in the global
IVF market.
Regional Analysis
North America to
Dominate the Market
·
North America, particularly the United States,
holds a significant share of the global ART market. This dominance is driven by
factors such as high infertility rates, increasing maternal age, and advanced
healthcare infrastructure.
·
Europe remains a robust market for ART, with
countries like Germany, France, and the UK at the forefront. The region
benefits from progressive healthcare policies, high success rates in ART
procedures, and strong patient demand.
·
The APAC region is experiencing rapid growth in
ART adoption, driven by rising infertility rates, delayed marriages, and
increasing awareness. Countries like India and China are witnessing a surge in
ART procedures, with India emerging as a hub for fertility tourism due to
cost-effective treatments.
·
Latin America is witnessing steady growth in ART
adoption, influenced by increasing awareness, improving healthcare
infrastructure, and supportive government policies. Countries like Brazil and
Mexico are leading the region in ART procedures.
·
The MEA region shows a growing interest in ART,
particularly in Gulf Cooperation Council (GCC) countries like the UAE and Saudi
Arabia, where cultural acceptance and healthcare infrastructure are improving.
Access Full Report: https://www.delvens.com/report/assisted-reproductive-technology-market
In addition to the
market data for the Assisted Reproductive Technology Market, Delvens offers
client-centric reports customized according to the company’s specific demand
and requirements.
Frequently Asked
Questions
·
What are the years considered to study Assisted
Reproductive Technology Market intelligence report?
·
What is the compound annual growth rate (CAGR)
of the Assisted Reproductive Technology Market?
·
Which region holds the largest market share in
Assisted Reproductive Technology Market?
·
Which region is the fastest growing in Assisted
Reproductive Technology Market?
·
Who are the major players in Assisted
Reproductive Technology Market?
More Related Reports:
Precision Diagnostics and Medicine Market
About Us:
Delvens is a strategic advisory and consulting company
headquartered in New Delhi, India. The company holds expertise in providing
syndicated research reports, customized research reports and consulting
services. Delvens qualitative and quantitative data is highly utilized by each
level from niche to major markets, serving more than 1K prominent companies by
assuring to provide the information on country, regional and global business
environment. We have a database for more than 45 industries in more than 115+
major countries globally.
Delvens database assists the clients by providing in-depth
information in crucial business decisions. Delvens offers significant facts and
figures across various industries namely Healthcare, IT & Telecom,
Chemicals & Materials, Semiconductor & Electronics, Energy,
Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our
company provides an exhaustive and comprehensive understanding of the business
environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301,
IN
+44 20 3290 6466
+0120- 4903958
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.